The G - 217A variant of the angiotensinogen gene affects basal transcription and is associated with hypertension in a Taiwanese population

Journal of Hypertension

Volumn 21, Issue 11, 2003, Pages 2061-2067

  Wu, Shyh Jong ^a   Chiang, Fu Tien ^b   Jiang, Jun Ran ^c   Hsu, Kwan Lih ^b   Chern, Tser Haw ^b   Tseng, Yung Zu ^b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Angiotensinogen; Case control study; Gene regulation; Hypertension; Polymorphisms; Taiwanese; Transfection

Indexed keywords

ANGIOTENSIN; NUCLEIC ACID BASE;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; ASSAY; BLOOD PRESSURE; CELL LINE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; ESSENTIAL HYPERTENSION; ETHNIC GROUP; ETHNOLOGY; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE FUNCTION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GENETIC VARIABILITY; GENOTYPE; HIGH RISK POPULATION; HOMOZYGOSITY; HUMAN; HUMAN CELL; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MAMMAL CELL; MOLECULAR CLONING; NUCLEIC ACID BASE SUBSTITUTION; POPULATION; PRIORITY JOURNAL; PROMOTER REGION; RECESSIVE GENE; REPORTER GENE; TAIWAN;

EID: 1542360033     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200311000-00015     Document Type: Article

References (34)

1. Gould AB, Green B. Kinetics of the human renin and human renin substrate reaction. Cadiovasc Res 1971; 5:86-89.
2. Reid IA, Morris BJ, Ganong WF. The renin-angiotensin system. Annu Rev Physiol 1978; 40:377-410.
3. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charru A, et al. Molecular basis of human hypertension: role of angiotensinogen. Cell 1992; 71:169-180.
4. Smithies O, Kim HS. Targeted gene duplication and disruption for analyzing quantitative genetic traits in mice. Proc Natl Acad Sci USA 1994; 91:3612-3615.
5. Smithies O, Maeda N. Gene targeting approaches to complex genetic diseases: atherosclerosis and essential hypertension. Proc Natl Acad Sci USA 1995; 92:5266-5272.
6. Jeunemaitre X, Inoue I, Williams C, Charru A, Tichet J, Powers M, et al. Haplotypes of angiotensinogen in essential hypertension. Am J Hum Genet 1997; 60:1448-1460.
7. Cauffield M, Lavender P, Newell-Price J, Farrall M, Kamdar S, Daniel H, et al. Linkage of the angiotensinogen gene locus to human essential hypertension in African Caribbeans. J Clin Invest 1995; 96:687-692.
8. Kamitani A, Rakugi H, Higaki J, Yi Z, Mikami H, Miki T, et al. Association analysis of a polymorphism of the angiotensinogen gene with essential hypertension in Japanese. J Hum Hypertens 1994; 8:521-524.
9. Rotimi C, Cooper R, Ogunbiyi O, Morrison L, Ladipo M, Tewksbury D, et al. Hypertension, serum angiotensinogen, and molecular variants of the angiotensinogen gene among Nigerians. Circulation 1997; 95:2348-2350.
10. Iso H, Harada S, Shimamoto T, Sato S, Kitamura A, Sankai T, et al. Angiotensinogen T174M and M235T variants, sodium intake and hypertension among non-drinking, lean Japanese men and women. J Hypertens 2000; 18:1197-1206.
11. Hunt SC, Cook NR, Oberman A, Cutler JA, Hennekens CH, Allender PS, et al. Angiotensinogen genotype, sodium reduction, weight loss, and prevention of hypertension: trials of hypertension prevention, phase II. Hypertension 1998; 32:393-401.
12. Pratt JH, Ambrosius WT, Tewksbury DA, Wagner MA, Zhou L, Hanna MP. Serum angiotensinogen concentration in relation to gonadal hormones, body size, and genotype in growing young people. Hypertension 1998; 32:875-879.
13. Wang WY, Glenn CL, Zhang W, Benjafield AV, Nyholt DR, Morris BJ. Exclusion of angiotensinogen gene in molecular basis of human hypertension: sibpair linkage and association analyses in Australian anglocaucasians. Am J Med Genet 1999; 87:53-60.
14. Kato N, Sugiyama T, Morita H, Kurihara H, Yamori Y, Yazaki Y. Angiotensinogen gene and essential hypertension in the Japanese: extensive association study and meta-analysis on six reported studies. J Hypertens 1999; 17:757-763.
15. Brand E, Chatelain N, Keavney B, Caulfield M, Citterio L, Connell J, et al. Evaluation of the angiotensinogen locus in human essential hypertension: a European study. Hypertension 1998; 31:725-729.
16. Niu T, Xu X, Cordell HJ, Rogus J, Zhou Y, Fang Z, et al. Linkage analysis of candidate genes and gene-gene interactions in Chinese hypertensive sib pairs. Hypertension 1999; 33:1332-1337.
17. Inoue I, Nakajima T, Williams CS, Quackenbush J, Puryear R, Powers M, et al. A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest 1997; 99:1786-1797.
18. Ishigami T, Tamura K, Fujita T, Kobayashi I, Hibi K, Kihara M, et al. Angiotensinogen gene polymorphism near transcription start site and blood pressure: role of a T-to-C transition at intron I. Hypertension 1999; 34:430-434.
19. Wu SJ, Chiang FT, Jiang JR, Hsu KL, Chern TH, Tseng YZ. Molecular variants of angiotensinogen gene promoter affect in-vitro basal transcription [Abstract]. The 24th Annual Scientific Meeting of Japanese Society of Hypertension, Osaka, Japan; 2001.
20. Chiang FT, Hsu KL, Tseng CD, Hsiao WH, Lo HM, Chern TH, et al. Molecular variant M235T of the angiotensinogen gene is associated with essential hypertension in Taiwanese. J Hypertens 1997; 15:607-611.
21. Nakabayashi H, Taketa K, Miyano K, Yamane T, Sato J. Growth of human hepatoma cells lines with differentiated functions in chemically defined medium. Cancer Res 1982; 42:3858-3863.
22. Tienari PJ, Terwilliger JD, Ott J, Palo J, Peltonen L. Two-locus linkage analysis in multiple sclerosis (MS). Genomics 1994; 19:320-325.
23. Jain S, Tang X, Narayanan CS, Agarwal Y, Peterson SM, Brown CD, et al. Angiotensinogen gene polymorphism at -217 affects basal promoter activity and is associated with hypertension in African-Americans. J Biol Chem 2002; 277:36889-36896.
24. Gaillard I, Clauser E, Corvol P. Structure of human angiotensinogen gene. DNA 1989; 8:87-99.
25. Yanai K, Nibu Y, Murakami K, Fukamizu A. A cis-acting DNA element located between TATA box and transcription initiation site is critical in response to regulatory sequences in human angiotensinogen gene. J Biol Chem 1996; 271:15981-15986.
26. Yanai K, Saito T, Hirota K, Kobayashi H, Murakami K, Fukamizu A. Molecular variation of the human angiotensinogen core promoter element located between the TATA box and transcription initiation site affects its transcriptional activity. J Biol Chem 1997; 272:30558-30562.
27. Brasier AR, Li J. Mechanisms for inducible control of angiotensinogen gene transcription. Hypertension 1996; 27:465-475.
28. Brasier AR, Han Y, Sherman CT. Transcriptional regulation of angiotensinogen gene expression. Vitam Horm 1999; 57:217-247.
29. Sherman CT, Brasier AR. Role of signal transducers and activators of transcription 1 and -3 in inducible regulation of the human angiotensinogen gene by interleukin-6. Mol Endocrinol 2001; 15:441-457.
30. Cvetkovic B, Keen HL, Zhang X, Davis D, Yang B, Sigmund CD. Physiological significance of two common haplotypes of human angiotensinogen using gene targeting in the mouse. Physiol Genomics 2002; 11:253-262.
31. Paillard F, Chansel D, Brand E, Benetos A, Thomas F, Czekalski S, et al. Genotype-phenotype relationships for the renin-angiotensin-aldosterone system in a normal population. Hypertension 1999; 34:423-429.
32. Niu T, Xu X, Rogus J, Zhou Y, Chen C, Yang J, et al. Angiotensinogen gene and hypertension in Chinese. J Clin Invest 1998; 101:188-194.
33. Liu Y, Qin W, Hou S, Shan G, Zhuo M, Chen Y, et al. A - 6G variant of the angiotensinogen gene and essential hypertension in Han, Tibetan, and Yi populations. Hypertens Res 2001; 24:159-163.
34. Doris PA. Hypertension genetics, single nucleotide polymorphisms, and the common disease: common variant hypothesis. Hypertension 2002; 39:323-331.